George Arida is currently the Chief Financial and Operating Officer at BlueWillow Biologics, Inc., and serves as a Venture Fund Manager and Business Development Advisor at Harrington Discovery Institute at University Hospitals. With a strong focus on healthcare investments, George has been involved in various roles, including Board Observer and Liaison for Aleta Therapeutics and Epitopea, and Board Member for Pops. As Managing Director at 30Ventures and a former Venture Advisor and Managing Director at Venture Investors, George has extensive experience in venture funding with a cumulative management of $200 million AUM. Board leadership roles at Chromatin, Juventas Therapeutics, and Celleration reflect a consistent commitment to advancing biotechnology initiatives. George holds an MBA with High Honors from the University of Chicago and a Bachelor of Science in Chemical Engineering from the University of Illinois Urbana-Champaign.
This person is not in any teams
Harrington Discovery Institute at University Hospitals
The Harrington Discovery Institute at University Hospitals in Cleveland, OH – part of The Harrington Project for Discovery & Development – aims to advance medicine and society by enabling our nation’s most inventive scientists to turn their discoveries into medicines that improve human health. Harrington Discovery Institute was created in 2012 with a $50 million founding gift from the Harrington family and instantiates the commitment they share with University Hospitals to a Vision for a ‘Better World’.